Home ›
Trademark Categories ›
Pharmaceuticals ›
2014 ›
VI ›
VIEKIRAX
Trademark search for:
VIEKIRAX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-06-13 — Application filed
2014-06-17 — Application filed
2014-06-23 — Application filed
2014-09-09 — Assigned to examiner
2014-09-16 — Suspension letter written
2014-09-16 — Notification of letter of suspension e-mailed
2014-09-16 — Letter of suspension e-mailed
2015-02-11 — Teas response to suspension inquiry received
2015-02-11 — Correspondence received in law office
2015-02-12 — Teas/email correspondence entered
2015-03-04 — Suspension letter written
2015-03-04 — Letter of suspension e-mailed
2015-03-04 — Notification of letter of suspension e-mailed
2015-09-22 — Assigned to lie
2015-09-23 — Suspension checked - to attorney for action
2015-10-19 — Assigned to examiner
2015-10-21 — Approved for pub - principal register
2015-10-22 — Law office publication review completed
2015-11-04 — Notification of notice of publication e-mailed
2015-11-24 — Published for opposition
2015-11-24 — Official gazette publication confirmation e-mailed
2016-01-19 — Noa e-mailed - sou required from applicant
2016-08-22 — Application abandoned
2016-08-22 — Application abandoned
2016-08-22 — Final status recorded
Owner Information
AbbVie Inc.
North Chicago , IL
AbbVie Inc.
North Chicago , IL
Correspondent
CHERYL A. WITHYCOMBE ABBVIE INC. 1 N WAUKEGAN RD NORTH CHICAGO, IL 60064-1802 UNITED STATES
Filing Details
Filing Date:
2014-06-13
Status Date:
2016-08-22
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.